Corcept Therapeutics
CORT
#2310
Rank
NZ$13.90 B
Marketcap
NZ$129.55
Share price
3.81%
Change (1 day)
10.59%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.75

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.77. In 2025 the company made an earnings per share (EPS) of NZ$1.62 a decrease over its 2024 EPS that were of NZ$2.32.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.75-53.86%
2025NZ$1.62-30.37%
2024NZ$2.32
2022NZ$1.63-2.06%
2021NZ$1.675.43%
2020NZ$1.5810.84%
2019NZ$1.4327.69%
2018NZ$1.12-42.48%
2017NZ$1.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.01 1,841.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.06 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.51 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.11 690.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.12 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.17-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.86-211.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.41 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA